BridgeMD
New treatment option for Myocardial Infarction (MI)
Official title Contribution of Myocardial Perfusion Imaging in the Initial Assessment of Acute Coronary Syndromes Without ST Elevation for the Diagnosis of Myocardial Infarction or Differential Diagnoses
ClinicalTrials.gov ID: NCT07112820
What this study is testing
- What it's testing
- Patients with myocardial infarction require invasive treatment involving coronary angiography to confirm the diagnosis and, in most cases, treatment by angioplasty/stenting. Trans-thoracic ultrasound is central to the initial management of patients admitted to hospital with acute coronary syndrome without ST segment elevation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient over 18 years of age
- Hospitalised in cardiology as an emergency for acute coronary syndrome without ST segment elevation with indication for coronary angiography within...
- Not yet undergone coronary angiography.
- Troponin \>99th percentile, i.e. \>27ng/l (troponin I, hypersensitive, Abbott)
- With de novo segmental kinetic disorder on TTE or ECG repolarisation disorder outside ST elevation
You likely can't join if
- Haemodynamically unstable patient: HR \> 100 and/or systolic blood pressure \< 90 mmHg and/or diastolic blood pressure \< 60 mmHg and/or oxygen...
- Rhythmically unstable patient: sustained ventricular tachycardia, sudden death recovered.
- Patient with a known allergy to ultrasound contrast medium
- Patient with ST segment elevation.
- Patient with a contraindication to MRI.
- Patient with a caricatured picture of myocarditis (fever and/or significant biological inflammatory syndrome with CRP\>50mg/l)
See the full eligibility criteria
- Patient over 18 years of age
- Hospitalised in cardiology as an emergency for acute coronary syndrome without ST segment elevation with indication for coronary angiography within 72 hours of admission
- Not yet undergone coronary angiography.
- Troponin \>99th percentile, i.e. \>27ng/l (troponin I, hypersensitive, Abbott)
- With de novo segmental kinetic disorder on TTE or ECG repolarisation disorder outside ST elevation
- Patient affiliated with a health insurance scheme
- French-speaking patient
- Patient who has given their free, informed and written consent
- Haemodynamically unstable patient: HR \> 100 and/or systolic blood pressure \< 90 mmHg and/or diastolic blood pressure \< 60 mmHg and/or oxygen saturation \< 92% in AA and/or clinical signs of hypoperfusion (mottling...
- Rhythmically unstable patient: sustained ventricular tachycardia, sudden death recovered.
- Patient with a known allergy to ultrasound contrast medium
- Patient with ST segment elevation.
- Patient with a contraindication to MRI.
- Patient with a caricatured picture of myocarditis (fever and/or significant biological inflammatory syndrome with CRP\>50mg/l)
- Patients already included in a type 1 treatment research protocol (RIPH1)
- Patients under guardianship or curatorship
- Patients deprived of their liberty
- Patients under judicial protection
- Pregnant or breastfeeding patients (negative pregnancy test for women of childbearing age)
The study team makes the final eligibility decision.
Where it's taking place
- Paris, Ilede France, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, Ilede France, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.